神经科指南

订阅

MedSci主页 / 所有栏目 / 神经科指南

2020 共识指南：Rett综合征的终身管理

2020-09-13 国外儿科相关医学专家组（统称） BMJ Paediatr Open . 2020 Sep 13;4(1)

Rett综合征

Rett综合征是一种具有复杂共病的严重的神经发育障碍，本文主要目的是针对Rett综合征的终身管理提供共识指导。

中文标题：

2020 共识指南：Rett综合征的终身管理

英文标题：

Consensus guidelines on managing Rett syndrome across the lifespan

发布机构：

国外儿科相关医学专家组（统称）

发布日期：

2020-09-13

简要介绍：

Rett综合征是一种具有复杂共病的严重的神经发育障碍，本文主要目的是针对Rett综合征的终身管理提供共识指导。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 共识指南：Rett综合征的终身管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=5544f1c00198e8af, title=2020 共识指南：Rett综合征的终身管理, enTitle=Consensus guidelines on managing Rett syndrome across the lifespan, guiderFrom=BMJ Paediatr Open . 2020 Sep 13;4(1), authorId=0, author=, summary=Rett综合征是一种具有复杂共病的严重的神经发育障碍，本文主要目的是针对Rett综合征的终身管理提供共识指导。, cover=https://img.medsci.cn/2020106/1601997834223_2020535.jpg, journalId=0, articlesId=null, associationId=984, associationName=国外儿科相关医学专家组（统称）, associationIntro=null, copyright=0, guiderPublishedTime=Sun Sep 13 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>Rett综合征是一种具有复杂共病的严重的神经发育障碍，本文主要目的是针对Rett综合征的终身管理提供共识指导。</p> </div> </div> </div>, tagList=[TagDto(tagId=12695, tagName=Rett综合征)], categoryList=[CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=12695, guiderKeyword=Rett综合征, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3852, appHits=168, showAppHits=0, pcHits=984, showPcHits=3683, likes=0, shares=7, comments=6, approvalStatus=1, publishedTime=Wed Oct 07 00:06:44 CST 2020, publishedTimeString=2020-09-13, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Tue Oct 06 23:24:08 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 20:10:21 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 共识指南：Rett综合征的终身管理.pdf)])
2020 共识指南：Rett综合征的终身管理.pdf
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1068875, encodeId=ba0e10688e533, content=很有意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3a64817967, createdName=m18643d5f53m, createdTime=Wed Nov 10 07:59:38 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974005, encodeId=d7909e400541, content=很有指导意义！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb6a2875201, createdName=2673165518, createdTime=Wed Jun 16 09:17:56 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900798, encodeId=1632900e985d, content=非常有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211129/0708c577736746af9505e240c95bfe21/ed50f4e6812646388b702de78e18d26b.jpg, createdBy=e07e5430262, createdName=lexi Liao, createdTime=Fri Nov 20 14:58:50 CST 2020, time=2020-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895568, encodeId=3042895568c3, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83cb5430289, createdName=ms3000001410546383, createdTime=Fri Oct 30 04:48:36 CST 2020, time=2020-10-30, status=1, ipAttribution=)]
    2021-11-10 m18643d5f53m

    很有意义

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1068875, encodeId=ba0e10688e533, content=很有意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3a64817967, createdName=m18643d5f53m, createdTime=Wed Nov 10 07:59:38 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974005, encodeId=d7909e400541, content=很有指导意义！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb6a2875201, createdName=2673165518, createdTime=Wed Jun 16 09:17:56 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900798, encodeId=1632900e985d, content=非常有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211129/0708c577736746af9505e240c95bfe21/ed50f4e6812646388b702de78e18d26b.jpg, createdBy=e07e5430262, createdName=lexi Liao, createdTime=Fri Nov 20 14:58:50 CST 2020, time=2020-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895568, encodeId=3042895568c3, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83cb5430289, createdName=ms3000001410546383, createdTime=Fri Oct 30 04:48:36 CST 2020, time=2020-10-30, status=1, ipAttribution=)]
    2021-06-16 2673165518

    很有指导意义！

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1068875, encodeId=ba0e10688e533, content=很有意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3a64817967, createdName=m18643d5f53m, createdTime=Wed Nov 10 07:59:38 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974005, encodeId=d7909e400541, content=很有指导意义！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb6a2875201, createdName=2673165518, createdTime=Wed Jun 16 09:17:56 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900798, encodeId=1632900e985d, content=非常有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211129/0708c577736746af9505e240c95bfe21/ed50f4e6812646388b702de78e18d26b.jpg, createdBy=e07e5430262, createdName=lexi Liao, createdTime=Fri Nov 20 14:58:50 CST 2020, time=2020-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895568, encodeId=3042895568c3, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83cb5430289, createdName=ms3000001410546383, createdTime=Fri Oct 30 04:48:36 CST 2020, time=2020-10-30, status=1, ipAttribution=)]
    2020-11-20 lexi Liao

    非常有帮助

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1068875, encodeId=ba0e10688e533, content=很有意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3a64817967, createdName=m18643d5f53m, createdTime=Wed Nov 10 07:59:38 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974005, encodeId=d7909e400541, content=很有指导意义！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cb6a2875201, createdName=2673165518, createdTime=Wed Jun 16 09:17:56 CST 2021, time=2021-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=900798, encodeId=1632900e985d, content=非常有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211129/0708c577736746af9505e240c95bfe21/ed50f4e6812646388b702de78e18d26b.jpg, createdBy=e07e5430262, createdName=lexi Liao, createdTime=Fri Nov 20 14:58:50 CST 2020, time=2020-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895568, encodeId=3042895568c3, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83cb5430289, createdName=ms3000001410546383, createdTime=Fri Oct 30 04:48:36 CST 2020, time=2020-10-30, status=1, ipAttribution=)]
    2020-10-30 ms3000001410546383

    好

    0